A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults
Clinical trial NCT04886154 · COMPLETED
Trial details
- NCT number
- NCT04886154
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-14
- Primary completion
- 2024-02-02
- Enrollment
- 1440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.